Leerink Partners Reiterates Outperform Rating on Ultragenyx Pharma (RARE)
Go back to Leerink Partners Reiterates Outperform Rating on Ultragenyx Pharma (RARE)| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 25.83 +0.51 (2.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.32 | 52 Week High | $117.12 | |||
| Open | $25.76 | 52 Week Low | $46.52 | |||
| Day High | $26.75 | P/E | N/A | |||
| Day Low | $25.69 | EPS | $-1.97 | |||
| Volume | 2,396,402 | |||||
